Aluminum complexing enhances amyloid β protein penetration of blood-brain barrier

被引:81
作者
Banks, William A.
Niehoff, Michael L.
Drago, Denise
Zatta, Paolo
机构
[1] Vet Affairs Med Ctr, GRECC, St Louis, MO 63106 USA
[2] St Louis Univ, Sch Med, Div Geriatr, Dept Internal Med, St Louis, MO 63106 USA
[3] Univ Padua, Dept Biol, Unit Metalloprot, CNR Inst Biomed Technol, I-35100 Padua, Italy
关键词
Alzheimer's disease; amyloid beta protein; blood-brain barrier; aluminum; peptide; neurotoxicity;
D O I
10.1016/j.brainres.2006.07.112
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
A significant co-morbidity of Alzheimer's disease and cerebrovascular impairment suggests that cerebrovascular dysregulation is an important feature of dementia. Amyloid beta protein (A beta), a relevant risk factor in Alzheimer's disease, has neurotoxic properties and is thought to play a critical role in the cognitive impairments. Previously, we demonstrated that the 42mer of A beta (A beta 42) complexed with aluminum (Al-A beta 42) is much more cytotoxic than non-complexed A beta 42. The level of A beta in the brain is a balance between synthesis, degradation, and fluxes across the blood-brain barrier (BBB). In the present paper, we determined whether complexing with aluminum affected the ability of radioactively iodinated A beta to cross the in vivo BBB. We found that the rates of uptake of Al-A beta 42 and A beta 42 were similar, but that Al-A beta 42 was sequestered by brain endothelial cells much less than A beta 42 and so more readily entered the parenchymal space of the brain. Al-A beta 42 also had a longer half-life in blood and had increased permeation at the striatum and thalamus. Brain-to-blood transport was similar for Al-A beta 42 and A beta 42. In conclusion, complexing with aluminum affects some aspects of blood-to-brain permeability so that Al-A beta 42 would have more ready access to brain cells than A beta 42. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 64 条
[1]
AJAYA B, 1982, INDIAN J MED RES, V75, P607
[2]
ALFREY AC, 1972, T AM SOC ART INT ORG, V18, P257
[3]
DISSIMILAR ALUMINUM AND GALLIUM PERMEATION OF THE BLOOD-BRAIN-BARRIER DEMONSTRATED BY INVIVO MICRODIALYSIS [J].
ALLEN, DD ;
YOKEL, RA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) :903-908
[4]
AUDUS KL, 1988, RES COMMUN CHEM PATH, V60, P71
[5]
Brain clearance of Alzheimer's amyloid-β40 in the squirrel monkey:: A SPECT study in a primate model of cerebral amyloid angiopathy [J].
Bading, JR ;
Yamada, S ;
Mackic, JB ;
Kirkman, L ;
Miller, C ;
Calero, M ;
Ghiso, J ;
Frangione, B ;
Zlokovic, BV .
JOURNAL OF DRUG TARGETING, 2002, 10 (04) :359-368
[6]
Interactions of beta-amyloids with the blood-brain barrier [J].
Banks, WA ;
Kastin, AJ ;
Maness, LM ;
Banks, MF ;
Shayo, M ;
McLay, RN .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :190-199
[7]
Efflux of human and mouse amyloid β proteins 1-40 and 1-42 from brain:: Impairment in a mouse model of Alzheimer's disease [J].
Banks, WA ;
Robinson, SM ;
Verma, S ;
Morley, JE .
NEUROSCIENCE, 2003, 121 (02) :487-492
[8]
Aluminum-sensitive degradation of amyloid beta-protein(1-40) by murine and human intracellular enzymes [J].
Banks, WA ;
Maness, LM ;
Banks, MF ;
Kastin, AJ .
NEUROTOXICOLOGY AND TERATOLOGY, 1996, 18 (06) :671-677
[9]
ALUMINUM ALTERS THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER TO SOME NON-PEPTIDES [J].
BANKS, WA ;
KASTIN, AJ .
NEUROPHARMACOLOGY, 1985, 24 (05) :407-412
[10]
BANKS WA, 1988, J PHARMACOL EXP THER, V244, P579